NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,405 | +96.2% | 2,404 | +101.3% | 0.00% | – |
| Q2 2023 | $8,872 | +154.4% | 1,194 | +137.4% | 0.00% | – |
| Q1 2023 | $3,487 | -19.0% | 503 | +20.0% | 0.00% | – |
| Q4 2022 | $4,306 | -64.1% | 419 | -38.8% | 0.00% | – |
| Q3 2022 | $12,000 | -70.0% | 685 | -10.5% | 0.00% | – |
| Q2 2022 | $40,000 | -41.2% | 765 | -17.2% | 0.00% | – |
| Q1 2022 | $68,000 | -58.5% | 924 | -18.8% | 0.00% | – |
| Q4 2021 | $164,000 | -52.3% | 1,138 | -31.4% | 0.00% | – |
| Q3 2021 | $344,000 | -6.5% | 1,658 | -4.5% | 0.00% | – |
| Q2 2021 | $368,000 | +67.3% | 1,736 | +42.5% | 0.00% | – |
| Q1 2021 | $220,000 | +117.8% | 1,218 | +33.6% | 0.00% | – |
| Q4 2020 | $101,000 | +17.4% | 912 | +15.2% | 0.00% | – |
| Q3 2020 | $86,000 | +41.0% | 792 | +9.2% | 0.00% | – |
| Q2 2020 | $61,000 | +1933.3% | 725 | +222.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 225 | +2150.0% | 0.00% | – |
| Q4 2019 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |